Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids

PHASE4CompletedINTERVENTIONAL
Enrollment

506

Participants

Timeline

Start Date

November 18, 2005

Primary Completion Date

October 26, 2006

Study Completion Date

October 26, 2006

Conditions
Asthma
Interventions
DRUG

Fluticasone propionate

200μg twice daily

DRUG

Fluticasone propionate/salmeterol

50/100μg twice daily

Trial Locations (65)

1090

GSK Investigational Site, Brussels

2650

GSK Investigational Site, Edegem

3000

GSK Investigational Site, Leuven

8000

GSK Investigational Site, Bruges

9000

GSK Investigational Site, Ghent

GSK Investigational Site, Aalborg

16470

GSK Investigational Site, Saint-Michel

20014

GSK Investigational Site, San Sebastián

28006

GSK Investigational Site, Madrid

28009

GSK Investigational Site, Madrid

30900

GSK Investigational Site, Nîmes

37000

GSK Investigational Site, Tours

41071

GSK Investigational Site, Seville

54270

GSK Investigational Site, Essey-lès-Nancy

69120

GSK Investigational Site, Vaux En Velin

71100

GSK Investigational Site, Foggia

75019

GSK Investigational Site, Paris

75730

GSK Investigational Site, Paris

76000

GSK Investigational Site, Rouen

76031

GSK Investigational Site, Rouen

80138

GSK Investigational Site, Napoli

90127

GSK Investigational Site, Palermo

94800

GSK Investigational Site, Villejuif

115446

GSK Investigational Site, Moscow

119435

GSK Investigational Site, Moscow

119991

GSK Investigational Site, Moscow

167011

GSK Investigational Site, Syktyvkar

191144

GSK Investigational Site, St'Petersburg

630099

GSK Investigational Site, Novosibirsk

654063

GSK Investigational Site, Novokuznetsk

660022

GSK Investigational Site, Krasnoyarsk

5000 Odense C

GSK Investigational Site, Odense

06130

GSK Investigational Site, Grasse

02000

GSK Investigational Site, Laon

01100

GSK Investigational Site, Oyonnax

06122

GSK Investigational Site, Perugia

LV5403

GSK Investigational Site, Daugavpils

LV 1004

GSK Investigational Site, Riga

LV 1064

GSK Investigational Site, Riga

LT-50425

GSK Investigational Site, Kaunas

LT-72214

GSK Investigational Site, Tauragė

LT-10207

GSK Investigational Site, Vilnius

1315 RA

GSK Investigational Site, Almere Stad

5741 CG

GSK Investigational Site, Beek en Donk

5751 XJ

GSK Investigational Site, Deurne

7824 AA

GSK Investigational Site, Emmen

3851 EX

GSK Investigational Site, Ermelo

3435 CM

GSK Investigational Site, Nieuwegein

3207 NB

GSK Investigational Site, Spijkenisse

2517 EW

GSK Investigational Site, The Hague

4002 WP

GSK Investigational Site, Tiel

3447 GN

GSK Investigational Site, Woerden

N-3018

GSK Investigational Site, Drammen

N-2226

GSK Investigational Site, Kongsvinger

N-0855

GSK Investigational Site, Oslo

15-274

GSK Investigational Site, Bialystok

31-159

GSK Investigational Site, Krakow

93-513

GSK Investigational Site, Lodz

20-093

GSK Investigational Site, Lublin

634 050

GSK Investigational Site, Tomsk

04009

GSK Investigational Site, Almería

08035

GSK Investigational Site, Barcelona

SE-191 24

GSK Investigational Site, Sollentuna

SE-141 86

GSK Investigational Site, Stockholm

SE-171 76

GSK Investigational Site, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00353873 - Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids | Biotech Hunter | Biotech Hunter